Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05618249
Other study ID # 7600
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 1, 2020
Est. completion date August 30, 2020

Study information

Verified date December 2023
Source University Hospital, Strasbourg, France
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study would have as a starting point the results of a request carried out by the Medical Service Grand Est of the Health Insurance aiming to evaluate the number of boxes of PPI reimbursed in town pharmacy, in patients over 75 years old in the Grand Est of France from 01/01/2018 to 31/12/2018. It aims to highlight and quantify a possible inappropriate use of PPIs in private practice.


Recruitment information / eligibility

Status Completed
Enrollment 100
Est. completion date August 30, 2020
Est. primary completion date June 30, 2020
Accepts healthy volunteers
Gender All
Age group 75 Years and older
Eligibility Inclusion criteria: - Patient over 75 years of age - Patient with a PPI in the initial prescription - Patient seen at least once between 01/01/2018 and 31/11/2019 in the general practice - Patient who has not expressed his opposition, after information, to the reuse of his data for the purpose of this research. Exclusion criteria: - Patient having expressed his opposition to participate in the study - Impossibility to give the patient informed information (difficulties in understanding the subject, ...) - Patient under legal protection - Patient under guardianship or curatorship - Patient who is no longer followed up in the office following an entry into an institution (EHPAD)

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
France Service de Gériatrie - CHU de Strasbourg - France Strasbourg

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Strasbourg, France

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Retrospective systematic analysis of patient prescriptions to identify possible inappropriate use of PPIs in private practice Files analysed retrospectively from January 01, 2018 to December 31, 2019 will be examined
See also
  Status Clinical Trial Phase
Completed NCT01476995 - Prognostic Indicators as Provided by the EPIC ClearView N/A
Completed NCT00998075 - Study Comparing Esomeprazole and Acetylsalicylic Acid (ASA) Combined Together as One Capsule Versus These Medications Taken Separately Phase 1
Completed NCT02716025 - Serum Zinc, Peptic Ulcer Disease and H. Pylori Infection N/A
Terminated NCT01015729 - Study Comparing Esomeprazole and ASA Combined Together as One Capsule Versus These Medications Taken Separately Phase 1
Completed NCT02165488 - Frequent Ketamine Use and Gastrointestinal, Liver and Biliary Sequelae
Recruiting NCT03320538 - Efficacy and Safety of Hou Gu Mi Xi in Patients With Peptic Ulcer Diseases N/A
Completed NCT02332213 - Volatile Markers in Digestive Cancer
Completed NCT04918472 - Minimally Invasive Evaluation of Dyspepsia by Combined Magnetically Controlled Capsule Endoscopy and Urea Breath Test: a Pilot Prospective Cohort Study N/A